Sidorova I.S. Sidorova

Sidorova I.S. Sidorova

Auto-generated profile, based on publicly available information

Sidorova I.S. Sidorova

I.M. Sechenov First Moscow State Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
ISI.S. Sidorova
I.S. Sidorova
NNN.A. Nikitina
N.A. Nikitina
AUA.L. Unanyan
A.L. Unanyan
MAM.B. Ageev
M.B. Ageev

31 October 2018 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
UUUnanyan A.L. Unanyan
Unanyan A.L. Unanyan
SSSidorova I.S. Sidorova
Sidorova I.S. Sidorova
KEKogan Evgenija
Kogan Evgenija
BSBelogubova S.YU. Belogubova S
Belogubova S.YU. Belogubova S
TDTatiana Demura
Tatiana Demura
SSSizova N.M. Sizova
Sizova N.M. Sizova

31 January 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
SSSidorova I.S. Sidorova
Sidorova I.S. Sidorova
NNNikitina N.A. Nikitina
Nikitina N.A. Nikitina
GGGuseva E.V. Guseva
Guseva E.V. Guseva

21 December 2020 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
SSSidorova I.S. Sidorova
Sidorova I.S. Sidorova
NNNikitina N.A. Nikitina
Nikitina N.A. Nikitina
TTTardov M.V. Tardov
Tardov M.V. Tardov
SSStulin I.D. Stulin
Stulin I.D. Stulin

11 July 2024 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
NNNatalya A. Nikitina
Natalya A. Nikitina
ISIraida S. Sidorova
Iraida S. Sidorova
MRMaria Raigorodskaia
Maria Raigorodskaia
EMEkaterina A. Morozova
Ekaterina A. Morozova
STSergej A. Timofeev
Sergej A. Timofeev
РПРайгородская Мария Павловна
Райгородская Мария Павловна
BACKGROUND: Despite the retentive relevance of preeclampsia (PE) among the main causes of maternal morbidity and mortality, its etiology remains unclear. Despite gaps in its pathophysiology, highly effective methods of prognosis, prevention, and treatment are still not devised yet. In recent years, the use of microRNA molecules that epigenetically control the expression of target genes at the post-transcriptional level received great interest as are they of key importance in the proliferation, differentiation, invasion, migration, and apoptosis of trophoblast cells and regulation of angiogenesis, immune response, and other processes during pregnancy AIM: This study aimed to investigate the epigenetic mechanisms of PE development based on the evaluation of the expression of pathogenetically significant microRNAs in women’s blood plasma. MATERIALS AND METHODS: The study included 62 female patients divided into the main study group (n=42 with PE) and the control group (n = 20 healthy women with uncomplicated pregnancy, childbirth, and post-natal period). All patients have undergone general clinical, laboratory, and instrumental examinations. The expression levels of 15 microRNAs in the blood plasma were evaluated using a quantitative real-time polymerase chain reaction. DIANA miRPath v. 3.0 was used to evaluate the effect of differentially expressed microRNAs on the functioning of signaling pathways. Statistical data analyses were performed using Statistica 6.0. RESULTS: Multidirectional changes in the expression levels of 13 of 15 plasma microRNAs were found in the PE group compared with the control group; however, the expression levels of the following eight microRNAs decreased significantly: hsa-miR-146a-5p (p=0.011), hsa-miR-181a-5p (p=0.015), hsa-miR-210-3p (p=0.031), hsa-miR-517a-3p (p=0.004), hsa-miR-517c-3p (p=0.007), hsa-miR-574-3p (p=0.048), hsa-miR-574-5p (p=0.003), and hsa-miR-1304-5p (p=0.001). The expression levels of hsa-miR-20a-5p (FC=0.39; p=0.049) and hsa-miR-143-3p (FC=0.71, p=0.05) significantly decreased in pregnant women with PE and symptoms of fetal growth retardation (FGR) compared with the subgroup without FGR. No significant differences in the expression level of the analyzed microRNAs were found between the subgroups with moderate and severe PE and early and late PE. The functional evaluation of differentially expressed microRNAs among women with PE, considering the identification of their potential target genes, revealed the dysregulation of 40 signaling pathways and biological processes in which these molecules are involved. CONCLUSION: PE progresses alongside significant epigenetic changes accompanied by changes in the microRNA expression profile, which are associated with cardiovascular and cerebrovascular diseases and placental disorders. The detected differentially expressed microRNAs may be potential diagnostic markers of PE.

6 May 2019 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
SSSidorova I.S. Sidorova
Sidorova I.S. Sidorova
NNNikitina N.A. Nikitina
Nikitina N.A. Nikitina